Premium Nahrungsergänzungsmittel | artgerecht

Cimicifuga – Effects, Uses and Safety

Cimicifuga is a medicinal plant used to relieve menopausal symptoms. Its root contains bioactive compounds that may exert hormone-like effects on the body.

Regular tips about health Regular tips about health

Things worth knowing about "Cimicifuga"

Cimicifuga is a medicinal plant used to relieve menopausal symptoms. Its root contains bioactive compounds that may exert hormone-like effects on the body.

What is Cimicifuga?

Cimicifuga racemosa, commonly known as black cohosh (also classified scientifically as Actaea racemosa), is a perennial medicinal plant native to North America. It belongs to the buttercup family (Ranunculaceae). Indigenous peoples of North America traditionally used it to treat women's health issues and rheumatic complaints. Today, it is primarily used as a herbal remedy for menopausal symptoms and is approved as a medicinal product in many countries.

Active Compounds

The medically relevant active ingredients are found mainly in the root stock (rhizome) of the plant. The key compounds include:

Triterpene glycosides (e.g., actein, cimicifugoside): considered the primary active substances
Phenolic acids (e.g., isoferulic acid): with antioxidant properties
Flavonoids: supporting bioactive compounds
Alkaloids (e.g., N-methylserotonin): potentially involved in central nervous system effects

Mechanism of Action

The exact mechanism of action of cimicifuga has not yet been fully clarified. For a long time, it was assumed that the plant had phytoestrogenic properties -- that is, it acted similarly to estrogen. However, more recent studies suggest that its effects are primarily mediated through serotonergic and dopaminergic pathways in the brain, influencing hot flushes and mood changes. A direct activation of estrogen receptors is now considered less likely, which makes cimicifuga potentially relevant for women with hormone-sensitive conditions -- although medical advice is essential in these cases.

Medical Uses

Cimicifuga extracts are primarily used for the treatment of the following conditions:

Hot flushes and night sweats during menopause
Sleep disturbances and nervousness
Mood swings and depressive episodes during menopause
Premenstrual syndrome (PMS): investigated in some studies

In many countries, cimicifuga preparations are approved as herbal medicinal products (phytomedicines). The European Medicines Agency (EMA) has recognised a well-established use for cimicifuga dry extracts in the treatment of menopausal complaints.

Dosage and Usage Notes

The standard daily dose according to approvals and clinical studies is:

20–40 mg dry extract from the rhizome, usually as film-coated tablets or capsules
The duration of use should generally not exceed 6 months without consulting a physician

It is important to use standardised extracts and to follow the package instructions and medical guidance.

Safety and Side Effects

Cimicifuga is generally considered well tolerated when used as directed. Possible side effects include:

Gastrointestinal discomfort and nausea
Skin reactions (rare)
Headaches

In rare cases, liver damage has been reported in connection with cimicifuga preparations. A causal relationship has not been conclusively established; however, if symptoms such as jaundice, dark urine, or severe fatigue occur, a doctor should be consulted immediately.

Contraindications

Known hypersensitivity to cimicifuga or related plants
Existing liver disease
Pregnancy and breastfeeding (due to insufficient safety data)
Hormone-dependent conditions (e.g., estrogen-dependent breast cancer): only after medical consultation

Interactions

Cimicifuga may potentially interact with the following substances:

Hepatotoxic medications: increased risk of liver damage
Hormonal preparations (e.g., tamoxifen): possible impact on efficacy
Antihypertensive agents: potential additive effects

Scientific Evidence

Numerous clinical studies have investigated the efficacy of cimicifuga for menopausal symptoms. Several randomised controlled trials and meta-analyses demonstrate a significant reduction in hot flushes and an improvement in quality of life compared to placebo. The level of evidence is assessed by the EMA and various medical associations as sufficient to support clinical use, although further large-scale studies would be beneficial.

References

European Medicines Agency (EMA): Assessment report on Cimicifuga racemosa (L.) Nutt., rhizoma. EMA/HMPC/600717/2013.
Leach MJ, Moore V: Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews, 2012.
Borrelli F, Ernst E: Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. American Journal of Obstetrics and Gynecology, 2008.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.